Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

NWBO — Northwest Biotherapeutics, Inc. Dilution Risk Tracker

Track NWBO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NWBO — Get alerts when the score changes →

As of October 13, 2026, Northwest Biotherapeutics, Inc. (NWBO) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Northwest Biotherapeutics, Inc. has a market capitalization of $272.90M, 1.71B shares outstanding, 8 institutional holders tracked. Stored dilution-related fields include 91.24M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
95
📊 Float Risk
0
⚠️ Warrant Exposure
30
🔄 Convertible Debt
15

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 54%
🔄 Reverse Split model est. 70%
• 50-day avg $0.21 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise model 55%
• Critical: only 0.2 months cash remaining
📜 Warrant Exercise model 15%
• Warrant overhang: 5.3% of shares outstanding
🔔 Track NWBO — Get forecast alerts →

Market Data

Market Cap$272.90M
Shares Outstanding1.71B
Float1.61B
Cash$595.0K
Debt$54.07M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding1.71BVerified float table or market cache
Public Float1.61BVerified float table or market cache
Market Cap$272.90MMarket data cache
Cash Runway0.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants91.24MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 3.

Recent SEC source mix: EFFECT 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 86.6% shares (2026Q1 vs prior)
8 institutional holders · 406.6K shares
#1 KELLEHER FINANCIAL ADVISORS 200.0K shares
#2 VSM Wealth Advisory, LLC 80.6K shares
#3 Opus Capital Group, LLC 60.1K shares
+ 5 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest76.80M
Days to Cover12.3
% of Float4.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-14
xbrl XBRL CONVERTIBLE 2026-04-15
EFFECT EFFECT 2026-04-20
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NWBO Dilution Snapshot

Northwest Biotherapeutics, Inc. (NWBO) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NWBO's DilutionScore has held steady at 65/100 (High risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202665/100HIGH89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NWBO shares outstanding have increased 2.3% from 1.61B (Apr 2026) to 1.64B (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 20261.64B1.61B▲ 0.02%
May 17, 20261.61B1.61B▲ 2.27%
May 11, 20261.61B1.57B▲ 0.02%
Apr 26, 20261.61B1.57B▲ 0.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NWBO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NWBO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NWBO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations